Bioinformatic analysis of meningococcal Msf and Opc to inform vaccine antigen design

PLoS One. 2018 Mar 16;13(3):e0193940. doi: 10.1371/journal.pone.0193940. eCollection 2018.

Abstract

Neisseria meningitidis is an antigenically and genetically variable Gram-negative bacterium and a causative agent of meningococcal meningitis and septicaemia. Meningococci encode many outer membrane proteins, including Opa, Opc, Msf, fHbp and NadA, identified as being involved in colonisation of the host and evasion of the immune response. Although vaccines are available for the prevention of some types of meningococcal disease, none currently offer universal protection. We have used sequences within the Neisseria PubMLST database to determine the variability of msf and opc in 6,500 isolates. In-silico analysis revealed that although opc is highly conserved, it is not present in all isolates, with most isolates in clonal complex ST-11 lacking a functional opc. In comparison, msf is found in all meningococcal isolates, and displays diversity in the N-terminal domain. We identified 20 distinct Msf sequence variants (Msf SV), associated with differences in number of residues within the putative Vn binding motifs. Moreover, we showed distinct correlations with certain Msf SVs and isolates associated with either hyperinvasive lineages or those clonal complexes associated with a carriage state. We have demonstrated differences in Vn binding between three Msf SVs and generated a cross reactive Msf polyclonal antibody. Our study has highlighted the importance of using large datasets to inform vaccine development and provide further information on the antigenic diversity exhibited by N. meningitidis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adhesins, Bacterial / genetics
  • Amino Acid Sequence
  • Antigenic Variation / genetics
  • Antigens, Bacterial / genetics*
  • Bacterial Outer Membrane Proteins / genetics*
  • Computational Biology / methods
  • Genetic Variation / genetics
  • Humans
  • Meningitis, Meningococcal / immunology
  • Meningococcal Vaccines / genetics*
  • Neisseria meningitidis / genetics*
  • Sequence Alignment

Substances

  • Adhesins, Bacterial
  • Antigens, Bacterial
  • Bacterial Outer Membrane Proteins
  • Meningococcal Vaccines

Grants and funding

This work was funded by Meningitis Now (https://www.meningitisnow.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.